Trials / Conditions / Recurrent C. Difficile Infection
Recurrent C. Difficile Infection
3 registered clinical trials studyying Recurrent C. Difficile Infection.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) NCT05153499 | Finch Research and Development LLC. | Phase 3 |
| Completed | Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection NCT06669936 | Alexander Khoruts | — |
| Terminated | Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRI NCT03298048 | The University of Texas Health Science Center, Houston | Phase 2 |